Day: April 17, 2016
PHARMACEUTICALS
Wealthy Danish foundations keep pharma groups healthy
Denmark's biopharmaceutical sector, led by insulin giant Novo Nordisk, is experiencing a golden age as researchers reap the rewards of a unique ownership structure: deep-pocketed, non-profit foundations.